Mailbox
Favorites
Boards
The Hangout
NASDAQ
NYSE
OTC Markets
All Boards
Whats Hot!
Recent Activity
Most Viewed Boards
Most Viewed Posts
Most Posted
Most Followed
Top Boards
Newest Boards
Newest Members
Blog
Recent Blog Posts
Recently Updated
News
Stocks
Crypto
Investing
Business
Markets
Economy
Real Estate
Personal Finance
Market Movers
Interactive Charts
Login - Join Now FREE!
Home
›
Stock Message Boards
›
Stock Boards
›
CytoDyn Inc (CYDY) Message Board
Search
Search Type
Board
Post
Member
A Tweet in response to FDA's approval of Aduhelm..
Message Board
Public Reply
|
Private Reply
|
Keep
|
Replies
(1)
Post New Msg
Edit Msg
(
) |
Previous
|
Next
Post#
of 148278
(Total Views: 509)
Posted On: 06/07/2021 1:24:09 PM
Posted By:
Fumbler
A Tweet in response to FDA's approval of Aduhelm....
Bob Herman
@bobjherman
·
9m
Jaw on the floor: Biogen is charging a list price of $56,000 ($4,300 per infusion) for Aduhelm, a drug that *has not been proven to work*.
(3)
(0)
CytoDyn Inc (CYDY) Stock Research Links
CYDY Message Board
Company Profile
Time & Sales
Recent News
Filings
Financials
Buy Rating
Newer
Older
Scroll down for more posts ▼
